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Abstract
Background: Malaria fever is a common medical presentation and diagnosis in Malawi. The national malaria
policy supports self-diagnosis and self-medication for uncomplicated malaria with first line anti-malaria drugs.
While a qualitative appreciation of the burden of malaria on the health system is recognized, there is limited
quantitative estimation of the burden malaria exacts on the health system, especially with regard to human
resources and financial burden on Malawi.
Methods: The burden of malaria was assessed based on estimated incidence rates for a high endemic country of
which Malawi is one. Data on the available human resources and financial resources committed towards malaria
from official Malawi government documents and programme reports were obtained. The amount of human and
financial resources that would be required to treat 65% or 85% of symptomatic malaria cases as per the Roll Back
Malaria partnership and the US President's Malaria Initiative targets.
Results: Based on a malaria incidence rate of 1.4 episodes per year per person it was estimated that there would
be 3.71 million symptomatic episodes of malaria among children <5 years of age based on mid-2007 census
projections. At 0.59 episodes each year per person there would be 2.13 million episodes in the 5 to 14 year age
group and 1.02 million episodes in. There would be 761,848 malaria cases when HIV is not factored in among
those 15 years of age or above; this figure rose to 2.2 million when the impact of HIV in increasing malaria
incidence was considered. The prevalence of HIV has resulted in 42.3% increase in symptomatic malaria cases.
Treating 65% to 85% of cases would result in using 8.9% to 12.2% of the national health budget or 22.2% to 33.2%
of the national drug budget. Furthermore, having 65% to 85% of cases treated at a health facility would consume
55.5% to 61.1% of full-time equivalents of all the clinicians registered in the country. While this study's estimated
time of 5 and 10 minutes per consultation may differ in actual practice, due to time constraints patients may not
be seen for longer consultation in resources limited settings.
Conclusion: Malaria exacts a heavy toll on the health system in Malawi. The national recommendation of self-
medication with first-line drug for uncomplicated malaria is justified as there are not enough clinicians to provide
clinical care for all cases. The Malawi Ministry of Health's promotion of malaria drug prescription including other
lower cadre health workers may be justified.
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Background
Malaria is the leading cause of morbidity and mortality in
Malawi. Children under the age of 5 years and pregnant
women are especially vulnerable. The Ministry of Health
estimates that 40–50 percent of all out-patient health
facility attendances are due to malaria [1,2]. It has been
reported that an estimated 8 million symptomatic malaria
episodes occurs each year in a country of about 13 million
people [2].
The Malawi government through the National Malaria
Control Programme (NMCP) aims to reduce the public
health burden that malaria exacts on the country through
improved case management, intermittent presumptive
treatment of pregnant women and prevention mostly
through the promotion of the use of insecticide-treated
bed nets [1]. The treatment for uncomplicated malaria in
Malawi has been single dose oral sulphadoxine pyrimeth-
amine (SP) since 1993 [3-5]. Recently however the
Malawi Ministry of Health's Policy has changed based on
published results [3-5] from SP to a artemisinin-contain-
ing combination therapy (ACT), artemether-lafumentrine
(coarterm).
While the burden of malaria in terms of clinical outcomes
such as deaths, anaemia, prematurity and low birth
weight have been described [6-8], the toll that the disease
exacts on Malawi's human resources for health and the
national health budget has received limited attention. Yet
many health systems in developing countries are unable
to deliver adequate quality and quantity of health services
because of limited human resources for health (HRH)
available for service [9-11]. Malawi's health system has
experienced severe shortage of HRH from a combination
of factors: low output from the training institutions,
migration of health professionals and attrition to deaths
largely estimated to be from AIDS [12-14].
The main aim of the study was to estimate how much cli-
nician-time that malaria exacts on Malawi's Ministry of
Health resources. Secondary aims were to estimate the
proportion of finances that anti-malarial medications
exact on the country's health budget. Furthermore the
study also aimed to compare the estimated whether the
Malawi public health sector had adequate human
resources to provide treatment to 65 percent or 85 percent
of symptomatic malaria as per the Roll Back Malaria part-
nership and the US President's Malaria Initiative targets
[15,16]. Incidence of malaria in Malawi was based on the
MARA (Mapping Malaria Risk in Africa) index [17,18].
Methods
Population estimates and number of clinicians
The age-specific population estimates from the National
Statistical Office which were based on projections from
the 1998 Malawi Population and Housing Census [19].
By mid 2007, there were 2,648,694 persons <5 years,
3,612,050 ages 5 to 14 years and 6,925,888 for those aged
15 year or above.
The incidence of malaria
The incidence of symptomatic malaria by level of trans-
mission intensity and age group was estimated as reported
elsewhere [17,18]. As a high malaria endemic area the
incidence rate of malaria in Malawi was estimated at 1.4
episodes per-year among children less than 5 years of age,
0.59 episodes in the 5 to 14 years age group and 0.11 epi-
sodes per year for those 15 years or older The 2004 Malawi
Demographic and Health Survey estimated that 11.8 per-
cent of Malawians ≥ 15 years were infected with HIV [1].
HIV prevalence estimates in children are not known. This
then translate to 817,255 persons estimated to be HIV
infected in mid-2007.
Incidence rates of malaria among HIV infected adults in
Malawi have been estimated at 3.2, 4.9 and 5.4 per 1,000
person-years for those with CD4 count of >400/μL,
200–399/μl and <200/μL [12]. Based on the fact that
11.8% of adult Malawians were estimated to be infected
with HIV, the burden of malaria in this group based on
population estimated and incidence rates as reported by
Patnaik et al [20].
The national budget data to enable us assess what propor-
tion of the overall national health budget and drug budget
would malaria consume was obtained. Data for the
national expenditure was obtained from the Malawi Pov-
erty Reduction Strategy Report [21] and from a report by
Kabuluzi [2]. In Malawi, drugs are estimated to consume
30 percent of the total health affairs budget [21]. The esti-
mated medications cost for adult full course was US$ 1.35
and US$ 0.45 for <5 year olds and 5 to 14 year olds [22].
Number of clinicians in Malawi
There were 610 clinicians (physicians and clinical offic-
ers) registered with the Malawi Medical Council in
Malawi in 2005 [23]. There were also 485 registered med-
ical assistants. The total clinician pool was therefore
1,095; all clinician cadres included.
Results
The estimated case numbers of symptomatic malaria in 
Malawi
Based on a malaria incidence rate of 1.4 episodes per year,
there were an estimated 3,709,572 symptomatic episodes
of malaria among children <5 years old in 2005. At 0.59
episodes each year, there were 2,131,110 episodes in 5 to
14 year age group and 761,848 episodes in those aged 15
years or above. An estimated 6,602,530 episodes of
malaria would have occurred for the whole population.Malaria Journal 2007, 6:168 http://www.malariajournal.com/content/6/1/168
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These estimates were obtained without considering the
impact of HIV on malaria.
The estimated number of adult Malawians infected with
HIV in the ≥ 15 years age group, based on prevalence of
infection at 11.8 percent was 817,255. There is paucity of
data that have categorized CD4 count levels of HIV
infected Malawians at the population level. It is however
generally accepted that 15 percent of HIV infected have
CD4 counts less than 200/μL [11]. With 15 percent of
817,255 HIV infected persons with CD4 counts less than
200/μL and assuming the rest have CD4 counts greater
than 400/μL, the number of malaria episodes would be
2,222,934 for those will low CD4 counts and 661,975 for
those with CD4 counts of >400/μL. The total burden of
malaria among adult HIV infected persons would be
2,884,491 compared to 89,898 if HIV was not a factor
among this group i.e. a factor of 32 in the presence of HIV.
The total number of case in the whole population would
then be 9,397,123, an increase of 42.3 percent. The
budget and human resources burden that follow were esti-
mated with incidence estimates that factored in HIV's
influence in raising the incidence in the 15+ year old
group.
The burden of malaria on the national drug budget
A total US$ 54.3 million (MK 6,412.16 million) was
reported to have been spent on health affairs in the 2004/
2005 Malawi national budget. The drug budget was US$
19, 916,101.7. While assessing the cost of treating all cases
of malaria would be informative, that would probably be
unrealistic. It was therefore perceived that there was need
to assess the medication cost of treating 65 percent and 85
percent of all symptomatic cases as outlined in the Roll
Back Malaria partnership and the US President's Malaria
Initiative targets.
As shown in the tables 1,2,3 and 4, without factoring in
the contribution of HIV on malaria, drug costs for treat-
ment of uncomplicated malaria with coartem would con-
sume about 8.9–12.2 percent of the total national budget
and about 24.2–33.2 percent of the total drug budget. The
proportion of the amount of expenditure differed accord-
ing to whether only 65 percent or 85 percent of the cases
were being treated.
In 2005–6 financial year, the Malawi government allo-
cated US$ 23,080,000 as total funds for malaria treat-
ment, prevention and control [2]. This allocation came
from the country's own national budget, WHO, UNICEF,
USAID and the Global Fund. From these funds, Coartem
costs for all patients would cost 20.9–28.7 percent of that
budget.
The burden of malaria on the clinician pool
The clinician full time equivalents (FTEs) required to treat
65 percent and 85 percent of symptomatic malaria was
assessed based on an assumed patient-clinician contact
time of 5 minutes and 10 minutes. In fact Nsimba et al
[24] have reported a 3.8 minute consultation of under-
five children with fever in Tanzania. Makombe et al [25]
have reported that each health professional spends 4.4
work-days each week i.e. a total of 230 days each year pro-
viding clinical care. Each health professional would
potentially consult 11,040 patients each year at 10 min-
utes and twice the number at 5 minutes. To treat 65% and
85% of all the cases at 10 minutes per visit would require
553 and 724 clinicians respectively working full time i.e.
55.5 or 66.1 percent of all registered clinicians. The
number and proportions of clinicians required reduce by
half if a consultation time is reduced to 5 minutes.
Discussion
It was estimated that about 9.4 million cases of uncompli-
cated malaria would be expected to occur in Malawi in
2007/08. Comparing age groups 0 to 4 years, 5 to 14 years
and those >14 years, the number of cases were highest in
the youngest group i.e. about 3.7 million cases. Among
the oldest group, incidence increased by a factor of 42.3
percent when the impact of HIV in increasing incidence of
malaria was factored in.
Malawi, like many other African health systems, relies
heavily on non-physician clinicians [26]. Clinical care is,
therefore, provided by medical assistants, clinical officers
and physicians. It was estimated that 55.5 to 66.1 percent
of all registered clinicians would be required to treat 65
percent to 85 percent of the cases of uncomplicated symp-
tomatic malaria in the country. While it is currently unre-
alistic that all these cases would present for care, the
estimate still demonstrates that malaria is a large public
Table 1: Burden of malaria treatment on total national health budget at 65% clinical cases treated
Age group Estimated number of cases Total malaria drug costs in US$ Expressed as % of national health affairs budget
0–4 2,411,222 1,085,050 2.0
0 to 14 1,385,222 623,350 1.1
≥ 15 2,311,958 3,121,143 5.7
Total 6,108,402 4,829,543 8.9Malaria Journal 2007, 6:168 http://www.malariajournal.com/content/6/1/168
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health problem in Malawi. Probably a major finding of
the current assessment is that both the Roll Back Malaria
and the US President's Malaria Initiative targets are
unlikely to be achieved in Malawi for the treatment of
patients by medical assistants, clinical officers and medi-
cal doctors.
The Ministry of Health in Malawi promotes the mobiliza-
tion of community health workers and lower cadre health
professionals for the management of malaria [22]. While
such recommendations are certainly realistic, they may
contribute to the development of antimalarial drug resist-
ance due to inappropriate use of medications by limited
trained health workers.
The burden that malaria would exact on the national
health affairs budget is large. However in practice, this is
not the case as patients self-medicate at home from drugs
obtained from various sources including grocery stores
and the private sector [27]. Also health facilities do not
always stock adequate medications all the time, so the
actual expense may be lower than what has been esti-
mated in the study. A recent survey of health facilities in
Lilongwe district, capital district of Malawi by Lufesi et al
found that the government-run Central Medical Stores
was only able to satisfy 63 percent of antimalarial drug
orders [28]. Some health facilities had no antimalarial on
the survey at some periods. This study had several limita-
tions. It was estimated that all symptomatic malaria epi-
sodes would be effectively treated at the first presentation.
Some cases would have to be re-treated with a second line
anti-malarial drug. It has also been previously reported
that in high endemic areas HIV increases the likelihood of
malaria to become severe [29]. With an adult HIV preva-
lence of 11.8 percent, many cases of malaria in this age
group have potential to becoming severe and therefore
not amenable to first line treatment regimen.
Furthermore, we assessed the clinician time requirements
based at 5 and 10 minutes consultations with patients.
This assumption of how much time may be committed
was based on the authors' experience in managing
p a t i e n t s  w i t h  m a l a r i a  i n  A f r i c a .  R o w e  e t  a l  [ 3 0 ]  h a v e
reported that 70% of clinicians in their study of malaria
management spent not more than 9 minutes per patient
consultation. In fact a third of their clinicians spent less
than 6 minutes per consult. This should not be seen as an
endorsement by the authors as to how much time ought
to be spent by clinicians on a single patient, but rather an
attempt to justify the current study's estimate of how
much time clinician may be actually devoting to care for
malaria patients.
The challenges experienced by the Central Medical Stores
in ensuring transparency of resources along the chain of
drug supply, distribution and eventual use have been
described by Lufesi et al [28]. Wastage is a constant threat
within the public sector in Malawi. Finally, while only
anti-malarial drug expenses were estimated, many
patients who present with malaria fever, myalgia, athral-
gia and other symptoms will also likely be prescribed
analgesics; thus an added medication cost. These esti-
mates have been restricted to financial resources within
the Ministry of Health and HRH within the whole sector.
The financial expenses of the medication costs within the
private sector have not been estimated. However, the find-
ings of the study clearly highlight how much resources the
country as a whole, requires to treat malaria.
Table 2: Burden of malaria treatment on total national health budget at 85% clinical cases treated
Age group Estimated number of cases Total malaria drug costs in US$ Expressed as % of national health affairs budget
0–4 3,153,136 1,418,911 2.6
0 to 14 1,811,444 815,150 1.5
≥ 15 3,023,330 4,383,285 8.1
Total 7,987,910 6,617,346 12.2
Table 3: Burden of malaria treatment on total national drug budget at 65% clinical cases treated
Age group Estimated number of cases Total malaria drug costs in US$ Expressed as % of national drug budget
0–4 2,411,222 1,085,050 5.4
0 to 14 1,385,222 623,350 3.1
≥ 15 2,311,958 3,121,143 15.7
Total 6,108,402 4,829,543 24.2Malaria Journal 2007, 6:168 http://www.malariajournal.com/content/6/1/168
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Conclusion
The financial and human resource burden let alone the
human suffering caused by malaria cannot be underesti-
mated especially in a country where the per capita spend-
ing on health is only $12, Community based preventive
approaches such as the use of insecticide treated bed nets,
proper drainage of stagnant water, intermittent preventive
therapy of pregnant women and use of community "phar-
macies" e.g. grocery stores as distribution centers for
malaria drugs will be less costly. As the main provider of
healthcare, government needs to study disaggregated data
(qualitative and quantitative) pertaining to vertical pro-
grammes such as TB, HIV and malaria. This will help
health planners and policy makers in formulating policies
to improve the quality of services and efficient use of the
limited resources the country has.
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